Drug: Tocilizumab Injury: Epistaxis Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126071812 | Tocilizumab | Epistaxis | ROCHE | 51.11 YR | M | 105 KG | 20160817 | GB |
| 126824541 | Tocilizumab | Epistaxis | ROCHE | 79.00 YR | F | 0 | 20160825 | DE |
| 126891321 | TOCILIZUMAB | Epistaxis | AMGEN | 34.00 YR | M | 0 | 20160826 | CA |
| 126949221 | TOCILIZUMAB | Epistaxis | PFIZER | 34.00 YR | M | 0 | 20160829 | CA |
| 127100111 | TOCILIZUMAB | Epistaxis | ORION | 34.00 YR | M | 0 | 20160902 | CA |
| 127338771 | Tocilizumab | Epistaxis | ROCHE | 34.00 YR | M | 0 | 20160912 | CA |
Total Records: 6 Number of Pages: 1